URH-14988-95549
2 vaccinations
1 coded response
16 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 816 / CO
- Registered
- 2021-04-01
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-01
Registered in v-safe
-
2021-04-01
Dose 1 — Pfizer-BioNTech
- 2021-04-01
- 2021-04-02
- 2021-04-06
- 2021-04-07
- 2021-04-10
- 2021-04-15
-
2021-04-22
Dose 2 — Pfizer-BioNTech
- 2021-04-22
-
2021-04-23
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-04-24
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-25
- 2021-04-29
- 2021-05-15
- 2021-05-20
- 2021-05-29
-
2021-07-24
Survey response — 3 months, dose 2MedDRA: Nasopharyngitis — Feeling: GoodFree text: I believe a had a summer cold around the end of June/early July.MedDRA releases: 2021-09,2024-11 · check-in free text available
- 2022-04-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-01 | Pfizer-BioNTech | |
| 2 | 2021-04-22 | Pfizer-BioNTech |
Free text
Release 9 — 3 months, dose 2
Symptoms: I believe a had a summer cold around the end of June/early July.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release